Repligen Corp (NASDAQ:RGEN)
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions